Cargando…

A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells

Human exposure to carcinogens occurs via a plethora of environmental sources, with 70–90% of cancers caused by extrinsic factors. Aberrant phenotypes induced by such carcinogenic agents may provide universal biomarkers for cancer causation. Both current in vitro genotoxicity tests and the animal-tes...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilde, Eleanor C., Chapman, Katherine E., Stannard, Leanne M., Seager, Anna L., Brüsehafer, Katja, Shah, Ume-Kulsoom, Tonkin, James A., Brown, M. Rowan, Verma, Jatin R., Doherty, Ann T., Johnson, George E., Doak, Shareen H., Jenkins, Gareth J. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818597/
https://www.ncbi.nlm.nih.gov/pubmed/29110037
http://dx.doi.org/10.1007/s00204-017-2102-y
_version_ 1783301056852131840
author Wilde, Eleanor C.
Chapman, Katherine E.
Stannard, Leanne M.
Seager, Anna L.
Brüsehafer, Katja
Shah, Ume-Kulsoom
Tonkin, James A.
Brown, M. Rowan
Verma, Jatin R.
Doherty, Ann T.
Johnson, George E.
Doak, Shareen H.
Jenkins, Gareth J. S.
author_facet Wilde, Eleanor C.
Chapman, Katherine E.
Stannard, Leanne M.
Seager, Anna L.
Brüsehafer, Katja
Shah, Ume-Kulsoom
Tonkin, James A.
Brown, M. Rowan
Verma, Jatin R.
Doherty, Ann T.
Johnson, George E.
Doak, Shareen H.
Jenkins, Gareth J. S.
author_sort Wilde, Eleanor C.
collection PubMed
description Human exposure to carcinogens occurs via a plethora of environmental sources, with 70–90% of cancers caused by extrinsic factors. Aberrant phenotypes induced by such carcinogenic agents may provide universal biomarkers for cancer causation. Both current in vitro genotoxicity tests and the animal-testing paradigm in human cancer risk assessment fail to accurately represent and predict whether a chemical causes human carcinogenesis. The study aimed to establish whether the integrated analysis of multiple cellular endpoints related to the Hallmarks of Cancer could advance in vitro carcinogenicity assessment. Human lymphoblastoid cells (TK6, MCL-5) were treated for either 4 or 23 h with 8 known in vivo carcinogens, with doses up to 50% Relative Population Doubling (maximum 66.6 mM). The adverse effects of carcinogens on wide-ranging aspects of cellular health were quantified using several approaches; these included chromosome damage, cell signalling, cell morphology, cell-cycle dynamics and bioenergetic perturbations. Cell morphology and gene expression alterations proved particularly sensitive for environmental carcinogen identification. Composite scores for the carcinogens’ adverse effects revealed that this approach could identify both DNA-reactive and non-DNA reactive carcinogens in vitro. The richer datasets generated proved that the holistic evaluation of integrated phenotypic alterations is valuable for effective in vitro risk assessment, while also supporting animal test replacement. Crucially, the study offers valuable insights into the mechanisms of human carcinogenesis resulting from exposure to chemicals that humans are likely to encounter in their environment. Such an understanding of cancer induction via environmental agents is essential for cancer prevention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-017-2102-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5818597
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-58185972018-02-27 A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells Wilde, Eleanor C. Chapman, Katherine E. Stannard, Leanne M. Seager, Anna L. Brüsehafer, Katja Shah, Ume-Kulsoom Tonkin, James A. Brown, M. Rowan Verma, Jatin R. Doherty, Ann T. Johnson, George E. Doak, Shareen H. Jenkins, Gareth J. S. Arch Toxicol Genotoxicity and Carcinogenicity Human exposure to carcinogens occurs via a plethora of environmental sources, with 70–90% of cancers caused by extrinsic factors. Aberrant phenotypes induced by such carcinogenic agents may provide universal biomarkers for cancer causation. Both current in vitro genotoxicity tests and the animal-testing paradigm in human cancer risk assessment fail to accurately represent and predict whether a chemical causes human carcinogenesis. The study aimed to establish whether the integrated analysis of multiple cellular endpoints related to the Hallmarks of Cancer could advance in vitro carcinogenicity assessment. Human lymphoblastoid cells (TK6, MCL-5) were treated for either 4 or 23 h with 8 known in vivo carcinogens, with doses up to 50% Relative Population Doubling (maximum 66.6 mM). The adverse effects of carcinogens on wide-ranging aspects of cellular health were quantified using several approaches; these included chromosome damage, cell signalling, cell morphology, cell-cycle dynamics and bioenergetic perturbations. Cell morphology and gene expression alterations proved particularly sensitive for environmental carcinogen identification. Composite scores for the carcinogens’ adverse effects revealed that this approach could identify both DNA-reactive and non-DNA reactive carcinogens in vitro. The richer datasets generated proved that the holistic evaluation of integrated phenotypic alterations is valuable for effective in vitro risk assessment, while also supporting animal test replacement. Crucially, the study offers valuable insights into the mechanisms of human carcinogenesis resulting from exposure to chemicals that humans are likely to encounter in their environment. Such an understanding of cancer induction via environmental agents is essential for cancer prevention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-017-2102-y) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-11-06 2018 /pmc/articles/PMC5818597/ /pubmed/29110037 http://dx.doi.org/10.1007/s00204-017-2102-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Genotoxicity and Carcinogenicity
Wilde, Eleanor C.
Chapman, Katherine E.
Stannard, Leanne M.
Seager, Anna L.
Brüsehafer, Katja
Shah, Ume-Kulsoom
Tonkin, James A.
Brown, M. Rowan
Verma, Jatin R.
Doherty, Ann T.
Johnson, George E.
Doak, Shareen H.
Jenkins, Gareth J. S.
A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells
title A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells
title_full A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells
title_fullStr A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells
title_full_unstemmed A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells
title_short A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells
title_sort novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells
topic Genotoxicity and Carcinogenicity
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818597/
https://www.ncbi.nlm.nih.gov/pubmed/29110037
http://dx.doi.org/10.1007/s00204-017-2102-y
work_keys_str_mv AT wildeeleanorc anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT chapmankatherinee anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT stannardleannem anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT seagerannal anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT brusehaferkatja anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT shahumekulsoom anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT tonkinjamesa anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT brownmrowan anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT vermajatinr anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT dohertyannt anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT johnsongeorgee anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT doakshareenh anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT jenkinsgarethjs anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT wildeeleanorc novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT chapmankatherinee novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT stannardleannem novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT seagerannal novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT brusehaferkatja novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT shahumekulsoom novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT tonkinjamesa novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT brownmrowan novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT vermajatinr novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT dohertyannt novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT johnsongeorgee novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT doakshareenh novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells
AT jenkinsgarethjs novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells